HomeNewsTrendsHealthImmune response induced by Omicron effectively neutralise Delta variant: ICMR study

Immune response induced by Omicron effectively neutralise Delta variant: ICMR study

The study was conducted on 39 individuals, of which 25 had taken both the doses of AstraZeneca COVID-19 vaccine, eight people had taken double dose of Pfizer jab, while six were unvaccinated.

January 26, 2022 / 16:33 IST
Image Source: Reuters

An ICMR study has demonstrated that individuals infected with Omicron have significant immune response which could neutralise not only the Omicron, but also other variants of concern, including the most prevalent Delta variant.

It suggests that the immune response induced by the Omicron could effectively neutralise the Delta variant, making the re-infection with Delta variant less likely, thereby displacing the Delta as dominant strain, the study said emphasising upon the need for Omicron-specific vaccine strategy.

The study was conducted on 39 individuals, of which 25 had taken both the doses of AstraZeneca COVID-19 vaccine, eight people had taken double dose of Pfizer jab, while six were unvaccinated.

Also, 28 of these 39 were mainly foreign returnees from the UAE, South/West/East Africa, Middle East, the US and the UK, and 11 people were their high-risk contacts.

All these individuals were infected with Omicron variant.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The study assessed the IgG antibody and Neutralizing Antibody (NAb) response in the people with breakthrough and natural COVID-19 infections.

"Our study demonstrated substantial immune response in the individuals infected with Omicron. The neutralizing antibodies could effectively neutralize the Omicron and other variants of concern (VOCs), including the most prevalent Delta variant,” the study stated.

The main limitation of this study are lesser participants in the unvaccinated group and the shorter window period post infection.

This could be the important reason for the low immune response specifically in the unvaccinated individuals against Omicron, the scientists stated.

The study has been conducted by ICMR scientists, including Pragya D Yadav, Gajanan N Sapkal, Rima R Sahay and Priya Abraham.

It is yet to be peer-reviewed and has been released on bioRxiv preprint server on January 26.

PTI
first published: Jan 26, 2022 04:33 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347